Repurposing the cardiac glycoside digoxin to stimulate myelin regeneration in chemically‐induced and immune‐mediated mouse models of multiple sclerosis is a research paper published in Glia (2022). On theSindex it has a DataRank of 0. It has been cited 15 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Multiple Sclerosis Society
Grant: FG20125‐A‐1(HET)
National Multiple Sclerosis Society
Grant: RG1807‐32005(BP)
National Institutes of Health
Grant: R21AI142059(SDM)
National Institutes of Health
Grant: R01NS099334(SDM,BP)
National Institutes of Health
Grant: R01NS109372(BP)
NIAID NIH HHS
Grant: R21 AI142059
NINDS NIH HHS
Grant: R01 NS034939
NIAID NIH HHS
Grant: R21 AI151438
NINDS NIH HHS
Grant: R01 NS099334
NINDS NIH HHS
Grant: R01 NS109372
National Institutes of Health
Grant: 5R21AI142059-02
Combining Immune Tolerance and Myelin Repair Therapy in T cell-driven MS Models
National Institutes of Health
Grant: 7R01NS109372-03
Reversible mRNA methylation in oligodendrocyte development and CNS myelination
National Institutes of Health
Grant: 5R01NS099334-04
Regulation of CD4+ T cell-mediated Demyelination Following Oligo Ablation
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals